glatiramer

Action and Spectrum

Drug Interaction

Adverse Reaction

1-10%: 

Anorexia 

Frequency undefined: 

Arthralgia 

Anxiety 

Asthenia 

Hypertonia 

Pain  

Infection 

Black Box Warning

Contraindication / Caution

Glatiramer is contraindicated in patients hypersensitive to the active ingredient. 

Pregnancy / Lactation

Pregnancy consideration:  

No adequate data is available regarding the usage of the drug during pregnancy.  

Breastfeeding warnings:  

No data is available regarding the secretion of the drug in breast milk. 

Pregnancy category: 

• Category A: well-controlled and Satisfactory studies do not show risk to the fetus in the first/later trimester.        
• Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women        
• Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.       
• Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.        
• Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.        
• Category N: There is no data available for the drug under this category 

Pharmacology

Adminstartion

Patient Information Leaflet

Patient information leaflet 

Generic Name: glatiramer 

Pronounced: gla-tir-am-er 

Why do we use glatiramer? 

glatiramer commonly known by its brand name Copaxone, is a medication used in the treatment of multiple sclerosis (MS). It is a disease-modifying therapy (DMT) that is primarily prescribed for relapsing forms of MS, including relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS).